keyword
https://read.qxmd.com/read/37575021/microglia-synapse-engulfment-via-ptdser-trem2-ameliorates-neuronal-hyperactivity-in-alzheimer-s-disease-models
#21
JOURNAL ARTICLE
Javier Rueda-Carrasco, Dimitra Sokolova, Sang-Eun Lee, Thomas Childs, Natália Jurčáková, Gerard Crowley, Sebastiaan De Schepper, Judy Z Ge, Joanne I Lachica, Christina E Toomey, Oliver J Freeman, John Hardy, Samuel J Barnes, Tammaryn Lashley, Beth Stevens, Sunghoe Chang, Soyon Hong
Neuronal hyperactivity is a key feature of early stages of Alzheimer's disease (AD). Genetic studies in AD support that microglia act as potential cellular drivers of disease risk, but the molecular determinants of microglia-synapse engulfment associated with neuronal hyperactivity in AD are unclear. Here, using super-resolution microscopy, 3D-live imaging of co-cultures, and in vivo imaging of lipids in genetic models, we found that spines become hyperactive upon Aβ oligomer stimulation and externalize phosphatidylserine (ePtdSer), a canonical "eat-me" signal...
August 14, 2023: EMBO Journal
https://read.qxmd.com/read/37449271/modeling-alzheimer-s-disease-related-phenotypes-in-the-ts65dn-mouse-impact-of-age-on-a%C3%AE-tau-ptau-nfl-and-behavior
#22
JOURNAL ARTICLE
Cassia Overk, Emma Fiorini, Chiara Babolin, Marija Vukicevic, Catherine Morici, Rime Madani, Valerie Eligert, Marie Kosco-Vilbois, Amanda Roberts, Ann Becker, Andrea Pfeifer, William C Mobley
INTRODUCTION: People with DS are highly predisposed to Alzheimer's disease (AD) and demonstrate very similar clinical and pathological features. Ts65Dn mice are widely used and serve as the best-characterized animal model of DS. METHODS: We undertook studies to characterize age-related changes for AD-relevant markers linked to Aβ, Tau, and phospho-Tau, axonal structure, inflammation, and behavior. RESULTS: We found age related changes in both Ts65Dn and 2N mice...
2023: Frontiers in Neuroscience
https://read.qxmd.com/read/37398396/novel-compound-inhibits-glycolysis-proteotoxicity-inflammation-and-impairments-in-animal-models-of-alzheimer-s-huntington-s-and-stroke-aging-as-a-consequence-of-glycolysis
#23
Rachel Litke, Kun-Hyung Roh, Yonejung Yoon, Sindhu Vangeti, Irene Ramos-Lopez, Husnu Kaniskan, Jian Jin, Christopher Kellner, Charles Mobbs
Alzheimer's Disease (AD) and other age-related diseases are increasingly among the most devastating strains on public health systems as the population ages, yet few treatments produce clinically significant protection. Although it is widely agreed that proteotoxicity drives impairments in AD and other neurological diseases, many preclinical and case-report studies indicate that increased microglial production of pro-inflammatory cytokines such as TNF-a mediate proteotoxicity in AD and other neurological conditions...
June 13, 2023: bioRxiv
https://read.qxmd.com/read/37329974/the-multifactorial-role-of-vanillin-in-amelioration-of-aluminium-chloride-and-d-galactose-induced-alzheimer-s-disease-in-mice
#24
JOURNAL ARTICLE
Abhinav Anand, Navneet Khurana, Satinder Kaur, Nemat Ali, Abdullah F AlAsmari, Mohammad Waseem, Muzaffar Iqbal, Faris M Alzahrani, Neha Sharma
The onset and progression of Alzheimer's disease (AD) are influenced by a variety of factors. These include oxidative stress, overexpression of acetylcholinesterase (AChE), depletion of acetylcholine levels, increased beta-secretase mediated conversion of Amyloid Precursor Protein (APP) to Amyloid Beta (Abeta), accumulation of Abeta oligomers, decrease in Brain Derived Neurotrophic factor (BDNF) and accelerated neuronal apoptosis due to elevated levels of caspase-3. The currently available therapeutic approaches are inadequate in affecting these pathological processes except maybe the overexpression of AChE (AChE inhibitors like donepezil, rivastigmine)...
June 15, 2023: European Journal of Pharmacology
https://read.qxmd.com/read/37240322/csf-biomarkers-in-the-early-diagnosis-of-mild-cognitive-impairment-and-alzheimer-s-disease
#25
REVIEW
Vasileios Papaliagkas, Kallirhoe Kalinderi, Patroklos Vareltzis, Despoina Moraitou, Theodora Papamitsou, Maria Chatzidimitriou
Alzheimer's disease (AD) is a rapidly growing disease that affects millions of people worldwide, therefore there is an urgent need for its early diagnosis and treatment. A huge amount of research studies are performed on possible accurate and reliable diagnostic biomarkers of AD. Due to its direct contact with extracellular space of the brain, cerebrospinal fluid (CSF) is the most useful biological fluid reflecting molecular events in the brain. Proteins and molecules that reflect the pathogenesis of the disease, e...
May 19, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/37236808/neuronally-derived-soluble-abeta-evokes-cell-wide-astrocytic-calcium-dysregulation-in-absence-of-amyloid-plaques-in-vivo
#26
JOURNAL ARTICLE
Patricia Kelly, Maria V Sanchez-Mico, Steven S Hou, Sara Whiteman, Alyssa Russ, Eloise Hudry, Michal Arbel-Ornath, Steven M Greenberg, Brian J Bacskai
The key pathologic entities driving the destruction of synaptic function and integrity during the evolution of Alzheimer's disease (AD) remain elusive. Astrocytes are structurally and functionally integrated within synaptic and vascular circuitry and use calcium-based physiology to modulate basal synaptic transmission, vascular dynamics, and neurovascular coupling, which are central to AD pathogenesis. We used high-resolution multiphoton imaging to quantify all endogenous calcium signaling arising spontaneously throughout astrocytic somata, primary processes, fine processes, and capillary endfeet in the brain of awake APP/PS1 transgenic mice (11 male and 6 female mice)...
June 28, 2023: Journal of Neuroscience
https://read.qxmd.com/read/37211499/lipopolysaccharide-immune-biomarkers-and-cerebral-amyloid-beta-deposition-in-older-adults-with-mild-cognitive-impairment-major-depressive-disorder
#27
JOURNAL ARTICLE
Vivian Feng, Krista Lanctot, Nathan Herrmann, Alex Kiss, Corinne E Fischer, Alastair J Flint, Linda Mah, Benoit H Mulsant, Bruce G Pollock, Tarek K Rajji, Shankar Tumati, Nicolaas Paul Verhoeff, Ariel Graff-Guerrero, Damien Gallagher
OBJECTIVE: Inflammatory activation and increased immune response to lipopolysaccharide occur in both depression and cognitive decline and may link these two conditions. We investigated whether lipopolysaccharide (LPS), LPS binding protein (LBP) and peripheral biomarkers of immune response were associated with increased cerebral deposition of amyloid-beta (Abeta) in older adults with mild cognitive impairment (MCI) and remitted major depressive disorder (rMDD). DESIGN: Cross-sectional analysis...
April 29, 2023: American Journal of Geriatric Psychiatry
https://read.qxmd.com/read/37210151/a-unique-color-coded-visualization-system-with-multimodal-information-fusion-and-deep-learning-in-a-longitudinal-study-of-alzheimer-s-disease
#28
JOURNAL ARTICLE
Mohammad Eslami, Solale Tabarestani, Malek Adjouadi
PURPOSE: Automated diagnosis and prognosis of Alzheimer's Disease remain a challenging problem that machine learning (ML) techniques have attempted to resolve in the last decade. This study introduces a first-of-its-kind color-coded visualization mechanism driven by an integrated ML model to predict disease trajectory in a 2-year longitudinal study. The main aim of this study is to help capture visually in 2D and 3D renderings the diagnosis and prognosis of AD, therefore augmenting our understanding of the processes of multiclass classification and regression analysis...
June 2023: Artificial Intelligence in Medicine
https://read.qxmd.com/read/37194165/outcomes-of-robot-assisted-versus-laparoscopic-surgery-for-colorectal-cancer-in-morbidly-obese-patients-a-propensity-score-matched-analysis-of-the-us-nationwide-inpatient-sample
#29
JOURNAL ARTICLE
Sin-Ei Juang, Kuan-Chih Chung, Kung-Chuan Cheng, Kuen-Lin Wu, Ling-Chiao Song, Chien-En Tang, Hong-Hwa Chen, Ko-Chao Lee
BACKGROUND AND AIM: Morbid obesity is associated with poorer postoperative outcomes in colorectal cancer (CRC) patients. We aimed to evaluate short-term outcomes after robotic versus conventional laparoscopic CRC resection in morbidly obese patients. METHODS: This population-based, retrospective study extracted data from the US Nationwide Inpatient Sample during 2005-2018. Adults ≥ 20 years old, with morbid obesity and CRC, and undergoing robotic or laparoscopic resections were identified...
May 16, 2023: Journal of Gastroenterology and Hepatology
https://read.qxmd.com/read/37109582/brain-region-specific-differences-in-amyloid-%C3%AE-plaque-composition-in-5xfad-mice
#30
JOURNAL ARTICLE
Angelika Sabine Bader, Marius-Uwe Gnädig, Merle Fricke, Luca Büschgens, Lena Josefine Berger, Hans-Wolfgang Klafki, Thomas Meyer, Olaf Jahn, Sascha Weggen, Oliver Wirths
Senile plaques consisting of amyloid-beta (Aβ) peptides are a major pathological hallmark of Alzheimer's disease (AD). Aβ peptides are heterogeneous regarding the exact length of their amino- and carboxy-termini. Aβ1-40 and Aβ1-42 are often considered to represent canonical "full-length" Aβ species. Using immunohistochemistry, we analyzed the distribution of Aβ1-x, Aβx-42 and Aβ4-x species in amyloid deposits in the subiculum, hippocampus and cortex in 5XFAD mice during aging...
April 20, 2023: Life
https://read.qxmd.com/read/36845656/white-matter-injury-cholesterol-dysmetabolism-and-app-abeta-dysmetabolism-interact-to-produce-alzheimer-s-disease-ad-neuropathology-a-hypothesis-and-review
#31
JOURNAL ARTICLE
Frank R Sharp, Charles S DeCarli, Lee-Way Jin, Xinhua Zhan
We postulate that myelin injury contributes to cholesterol release from myelin and cholesterol dysmetabolism which contributes to Abeta dysmetabolism, and combined with genetic and AD risk factors, leads to increased Abeta and amyloid plaques. Increased Abeta damages myelin to form a vicious injury cycle. Thus, white matter injury, cholesterol dysmetabolism and Abeta dysmetabolism interact to produce or worsen AD neuropathology. The amyloid cascade is the leading hypothesis for the cause of Alzheimer's disease (AD)...
2023: Frontiers in Aging Neuroscience
https://read.qxmd.com/read/36830020/oxidative-stress-in-brain-in-amnestic-mild-cognitive-impairment
#32
REVIEW
D Allan Butterfield
Amnestic mild cognitive impairment (MCI), arguably the earliest clinical stage of Alzheimer disease (AD), is characterized by normal activities of daily living but with memory issues but no dementia. Oxidative stress, with consequent damaged key proteins and lipids, are prominent even in this early state of AD. This review article outlines oxidative stress in MCI and how this can account for neuronal loss and potential therapeutic strategies to slow progression to AD.
February 11, 2023: Antioxidants (Basel, Switzerland)
https://read.qxmd.com/read/36784932/obtention-of-accurate-abeta-zn-ii-ensembles-from-molecular-modelling-and-bayesian-maximum-entropy-reweighing
#33
JOURNAL ARTICLE
Julen Aduriz
No abstract text is available yet for this article.
February 10, 2023: Biophysical Journal
https://read.qxmd.com/read/36641439/a-novel-human-tau-knock-in-mouse-model-reveals-interaction-of-abeta-and-human-tau-under-progressing-cerebral-amyloidosis-in-5xfad-mice
#34
JOURNAL ARTICLE
Susan Barendrecht, An Schreurs, Stefanie Geissler, Victor Sabanov, Victoria Ilse, Vera Rieckmann, Rico Eichentopf, Anja Künemund, Benjamin Hietel, Sebastian Wussow, Katrin Hoffmann, Kerstin Körber-Ferl, Ravi Pandey, Gregory W Carter, Hans-Ulrich Demuth, Max Holzer, Steffen Roßner, Stephan Schilling, Christoph Preuss, Detlef Balschun, Holger Cynis
BACKGROUND: Hyperphosphorylation and intraneuronal aggregation of the microtubule-associated protein tau is a major pathological hallmark of Alzheimer's disease (AD) brain. Of special interest is the effect of cerebral amyloid beta deposition, the second main hallmark of AD, on human tau pathology. Therefore, studying the influence of cerebral amyloidosis on human tau in a novel human tau knock-in (htau-KI) mouse model could help to reveal new details on their interplay. METHODS: We studied the effects of a novel human htau-KI under fast-progressing amyloidosis in 5xFAD mice in terms of correlation of gene expression data with human brain regions, development of Alzheimer's-like pathology, synaptic transmission, and behavior...
January 14, 2023: Alzheimer's Research & Therapy
https://read.qxmd.com/read/36633092/experimental-approaches-for-altering-the-expression-of-abeta-degrading-enzymes
#35
REVIEW
David A Loeffler
Cerebral clearance of amyloid β-protein (Aβ) is decreased in early-onset and late-onset Alzheimer's disease (AD). Aβ is cleared from the brain by enzymatic degradation and by transport out of the brain. More than 20 Aβ-degrading enzymes have been described. Increasing the degradation of Aβ offers an opportunity to decrease brain Aβ levels in AD patients. This review discusses the direct and indirect approaches which have been used in experimental systems to alter the expression and/or activity of Aβ-degrading enzymes...
January 12, 2023: Journal of Neurochemistry
https://read.qxmd.com/read/36613597/secondary-structure-in-amyloids-in-relation-to-their-wild-type-forms
#36
JOURNAL ARTICLE
Irena Roterman, Katarzyna Stapor, Leszek Konieczny
The amyloid structures and their wild type forms, available in the PDB database, provide the basis for comparative analyses. Globular proteins are characterised by a 3D spatial structure, while a chain in any amyloid fibril has a 2D structure. Another difference lies in the structuring of the hydrogen bond network. Amyloid forms theoretically engage all the NH and C=O groups of the peptide bonds in a chain with two hydrogen bonds each. In addition, the hydrogen bond network is highly ordered-as perpendicular to the plane of the chain...
December 21, 2022: International Journal of Molecular Sciences
https://read.qxmd.com/read/36448030/a-pathological-role-of-the-hsp40-protein-ydj1-dnaja1-in-models-of-alzheimer-s-disease
#37
COMMENT
Jelena Tadic, Julia Ring, Andrea Jerkovic, Selena Ristic, Marta Maglione, Jörn Dengjel, Stephan J Sigrist, Tobias Eisenberg
Alzheimer's disease (AD) is the most common form of dementia with millions of people affected worldwide. Pathophysiological manifestations of AD include the extracellular accumulation of amyloid beta (Abeta) pep-tides, products of the proteolytic cleavage of the amy-loid precursor protein APP. Increasing evidence sug-gests that Abeta peptides also accumulate intracellular-ly, triggering neurotoxic events such as mitochondrial dysfunction. However, the molecular factors driving formation and toxicity of intracellular Abeta are poorly understood...
May 2022: Cell Stress
https://read.qxmd.com/read/36419075/visinin-like-protein-1-levels-in-blood-and-csf-as-emerging-markers-for-alzheimer-s-and-other-neurodegenerative-diseases
#38
JOURNAL ARTICLE
Steffen Halbgebauer, Petra Steinacker, Daniel Riedel, Patrick Oeckl, Sarah Anderl-Straub, Jolina Lombardi, Christine A F von Arnim, Magdalena Nagl, Armin Giese, Albert C Ludolph, Markus Otto
BACKGROUND: Visinin-like protein 1 (VILIP-1) belongs to the group of emerging biomarkers with the potential to support the early diagnosis of Alzheimer's disease (AD). However, studies investigating the differential diagnostic potential in cerebrospinal fluid (CSF) are rare and are not available for blood. METHODS: We set up a novel, sensitive single molecule array (Simoa) assay for the detection of VILIP-1 in CSF and serum. In total, paired CSF and serum samples from 234 patients were investigated: 73 AD, 18 behavioral variant frontotemporal dementia (bvFTD), 26 parkinsonian syndromes, 20 amyotrophic lateral sclerosis (ALS), 22 Creutzfeldt-Jakob disease (CJD), and 75 non-neurodegenerative control (Con) patients...
November 22, 2022: Alzheimer's Research & Therapy
https://read.qxmd.com/read/36348973/sex-specific-biomarkers-in-alzheimer-s-disease-progression-framingham-heart-study
#39
JOURNAL ARTICLE
Chunyu Liu, Yi Li, Adaora Nwosu, Ting Fang Alvin Ang, Yulin Liu, Sherral Devine, Rhoda Au, P Murali Doraiswamy
Background: Sex differences in Alzheimer's disease (AD) are not well understood. Methods: We performed sex-specific analyses of AD and annualized cognitive decline with clinical and blood biomarker data in participants 60+ years old in the community-based longitudinal Framingham Heart Study Offspring Cohort ( n = 1398, mean age 68 years, 55% women). Results: During 11 years of follow-up, women were 96% more likely than men to be diagnosed with clinical AD dementia after adjusting for age and education in the younger age group 60 to 70 years ( n = 946; 95% confidence interval [CI], 1...
2022: Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
https://read.qxmd.com/read/36322251/amyloid-peptides-with-antimicrobial-and-or-microbial-agglutination-activity
#40
REVIEW
Dongru Chen, Xiangqi Liu, Yucong Chen, Huancai Lin
Microbe (including bacteria, fungi, and virus) infection in brains is associated with amyloid fibril deposit and neurodegeneration. Increasing findings suggest that amyloid proteins, like Abeta (Aβ), are important innate immune effectors in preventing infections. In some previous studies, amyloid peptides have been linked to antimicrobial peptides due to their common mechanisms in membrane-disruption ability, while the other mechanisms of bactericidal protein aggregation and protein function knockdown are less discussed...
November 2, 2022: Applied Microbiology and Biotechnology
keyword
keyword
11138
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.